• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

*As the coronavirus disease (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

The global metabolomics market is currently witnessing strong growth. Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

Global Metabolomics Market

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years. Looking forward, IMARC Group expects the market to grow at a CAGR of around 13% during 2020-2025.

Breakup by Product:

  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools and Services
     

Breakup by Indication:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others
     

Breakup by Application:

  • Biomarker and Drug Discovery
  • Toxicology
  • Nutrigenomics
  • Personalized Medicine
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global metabolomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metabolomics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Metabolomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Forecast
6    Market Breakup by Product
    6.1    Metabolomics Instruments
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Metabolomics Bioinformatics Tools and Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Indication
    7.1    Cancer
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular Disorders
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Neurological Disorders
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Inborn Errors of Metabolism
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by Application
    8.1    Biomarker and Drug Discovery
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Toxicology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Nutrigenomics
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Personalized Medicine
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Others
        8.5.1 Market Trends
        8.5.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Competitive Landscape
    13.1    Market Structure
    13.2    Key Players
    13.3    Profiles of Key Players
        13.3.1    Agilent Technologies Inc.
           13.3.1.1 Company Overview
           13.3.1.2 Product Portfolio 
           13.3.1.3 Financials
           13.3.1.4 SWOT Analysis
        13.3.2    Biocrates Life Sciences AG
           13.3.2.1 Company Overview
           13.3.2.2 Product Portfolio 
        13.3.3    Bio-Rad Laboratories Inc.
           13.3.3.1 Company Overview
           13.3.3.2 Product Portfolio 
           13.3.3.3 Financials
           13.3.3.4 SWOT Analysis
        13.3.4    Bruker Corporation
           13.3.4.1 Company Overview
           13.3.4.2 Product Portfolio 
           13.3.4.3 Financials
        13.3.5    Danaher Corporation
           13.3.5.1 Company Overview
           13.3.5.2 Product Portfolio 
           13.3.5.3 Financials
           13.3.5.4 SWOT Analysis
        13.3.6    Human Metabolome Technologies Inc.
           13.3.6.1 Company Overview
           13.3.6.2 Product Portfolio 
           13.3.6.3 Financials
        13.3.7    Metabolon Inc.
           13.3.7.1 Company Overview
           13.3.7.2 Product Portfolio 
        13.3.8    Shimadzu Corporation
           13.3.8.1 Company Overview
           13.3.8.2 Product Portfolio 
           13.3.8.3 Financials
           13.3.8.4 SWOT Analysis
        13.3.9    Thermo Fisher Scientific Inc.
           13.3.9.1 Company Overview
           13.3.9.2 Product Portfolio 
           13.3.9.3 Financials
           13.3.9.4 SWOT Analysis
        13.3.10    Waters Corporation
           13.3.10.1 Company Overview
           13.3.10.2 Product Portfolio 
           13.3.10.3 Financials
           13.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2014-2019
Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2019
Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2019
Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2019
Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2019
Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2020-2025
Figure 8: Global: Metabolomics (Metabolomics Instruments) Market: Sales Value (in Million US$), 2014 & 2019
Figure 9: Global: Metabolomics (Metabolomics Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 10: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2014 & 2019
Figure 11: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2014 & 2019
Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2014 & 2019
Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2014 & 2019
Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2014 & 2019
Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2014 & 2019
Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2014 & 2019
Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2014 & 2019
Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2014 & 2019
Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 76: Argentina: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 77: Argentina: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 78: Columbia: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 79: Columbia: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 80: Chile: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 81: Chile: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 82: Peru: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 83: Peru: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 84: Others: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 85: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 86: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2014 & 2019
Figure 87: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2020-2025
Figure 88: Global: Metabolomics Industry: SWOT Analysis
Figure 89: Global: Metabolomics Industry: Value Chain Analysis
Figure 90: Global: Metabolomics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Metabolomics Market: Key Industry Highlights, 2019 and 2025
Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2020-2025
Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2020-2025
Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2020-2025
Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2020-2025
Table 6: Global: Metabolomics Market: Competitive Structure
Table 7: Global: Metabolomics Market: Key Players        

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links